Literature DB >> 20579886

LGL can partition the cortex of one-cell Caenorhabditis elegans embryos into two domains.

Carsten Hoege1, Alexandru-Tudor Constantinescu, Anne Schwager, Nathan W Goehring, Prateek Kumar, Anthony A Hyman.   

Abstract

Many metazoan cell types are polarized by asymmetric partitioning of the conserved PAR (PAR-3/PAR-6/PKC-3) complex. Cortical domains containing this PAR complex are counterbalanced by opposing domains of varying composition. The tumor-suppressor protein LGL facilitates asymmetric localization of cell fate determinants, in part through modulating the activity of the PAR complex. However, the mechanisms by which LGL acts to maintain a cortical domain remain unclear. Here we identify Caenorhabditis elegans LGL in a biochemical complex with PAR proteins, which localize to the anterior cortex. But LGL itself localizes to the posterior cortex. We show that increasing the amounts of LGL can restrict localization of the PAR complex to an anterior cortical domain, even in the absence of PAR-2. Importantly, LGL must be phosphorylated on conserved residues to exert this function. LGL and the PAR complex can maintain two cortical domains that are sufficient to partition cell fate determinants. Our data suggest a mechanism of "mutual elimination" in which an LGL phosphorylation cycle regulates association of the PAR complex with the cortex: binding of LGL to the PAR complex at the interface of the two domains stimulates its phosphorylation by PKC-3, and the whole complex leaves the cortex. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579886     DOI: 10.1016/j.cub.2010.05.061

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  44 in total

1.  Signaling pathways in cell polarity.

Authors:  Luke Martin McCaffrey; Ian G Macara
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

2.  In Vivo Interaction Proteomics in Caenorhabditis elegans Embryos Provides New Insights into P Granule Dynamics.

Authors:  Jia-Xuan Chen; Patricia G Cipriani; Desirea Mecenas; Jolanta Polanowska; Fabio Piano; Kristin C Gunsalus; Matthias Selbach
Journal:  Mol Cell Proteomics       Date:  2016-02-24       Impact factor: 5.911

3.  The C. elegans homolog of Drosophila Lethal giant larvae functions redundantly with PAR-2 to maintain polarity in the early embryo.

Authors:  Alexander Beatty; Diane Morton; Kenneth Kemphues
Journal:  Development       Date:  2010-11-01       Impact factor: 6.868

Review 4.  Elaborating polarity: PAR proteins and the cytoskeleton.

Authors:  Jeremy Nance; Jennifer A Zallen
Journal:  Development       Date:  2011-03       Impact factor: 6.868

5.  Cortical forces and CDC-42 control clustering of PAR proteins for Caenorhabditis elegans embryonic polarization.

Authors:  Shyi-Chyi Wang; Tricia Yu Feng Low; Yukako Nishimura; Laurent Gole; Weimiao Yu; Fumio Motegi
Journal:  Nat Cell Biol       Date:  2017-07-24       Impact factor: 28.824

Review 6.  Development and dynamics of cell polarity at a glance.

Authors:  Joseph P Campanale; Thomas Y Sun; Denise J Montell
Journal:  J Cell Sci       Date:  2017-04-01       Impact factor: 5.285

7.  'Goldilocks' suppressor screen identifies web of polarity regulators.

Authors:  Geraldine Seydoux
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

Review 8.  Principles of PAR polarity in Caenorhabditis elegans embryos.

Authors:  Carsten Hoege; Anthony A Hyman
Journal:  Nat Rev Mol Cell Biol       Date:  2013-04-18       Impact factor: 94.444

9.  PAR-3 oligomerization may provide an actin-independent mechanism to maintain distinct par protein domains in the early Caenorhabditis elegans embryo.

Authors:  Adriana T Dawes; Edwin M Munro
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

10.  PAR-2, LGL-1 and the CDC-42 GAP CHIN-1 act in distinct pathways to maintain polarity in the C. elegans embryo.

Authors:  Alexander Beatty; Diane G Morton; Kenneth Kemphues
Journal:  Development       Date:  2013-03-27       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.